Bandingkan Harga & Kinerja Metropolitan Land Tbk. (MTLA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Metropolitan Land Tbk. dan Organon Pharma Indonesia Tbk.: Metropolitan Land Tbk. diperdagangkan di Rp535 (kapitalisasi pasar 4,13 T, volume 24 jam 32,9 rb), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Metropolitan Land Tbk. jauh lebih besar — sekitar 39,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| MTLA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 4,13 T | 104,4 M |
Volume | 32,9 rb | — |
Lot | 329 | — |
Perputaran | 17,14 jt | — |
Harga Rata-rata | 520,88 | — |
Nilai Transaksi | 17,14 jt | — |
Harga Ekuilibrium Indikatif | 530 | — |
Volume Ekuilibrium Indikatif | 53 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Metropolitan Land Tbk.
PT Metropolitan Land Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amenden by Law No. 12 year 1970 based on notarial deed No. 37 dated February 16, 1994 of Endang Irawati Ekaputri, S.H., Notary in Jakarta.
Selengkapnya di halaman MTLA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
